Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, clinical, and revenue cycle solutions, today announced that a broad set of its solutions has achieved HITRUST i1 Certification. The ...

Several hospital and health system chief information officers previously worked for EHR vendors, including Epic, Cerner, Meditech and Allscripts. Their ...

Independent physicians make up 42% of the U.S. physician workforce today — a substantial, resilient share of American ...

Boost ROI with AI scheduling, self-service booking and automated reminders that cut no-shows, reduce admin burden and improve capacity utilization.Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Medical ...

Veradigm stock was at USD 4.50 on October 5, 2026, while the 2025 revenue outlook stood at USD 584 million to USD 589 million. A USD 8.00 analyst target adds a separate valuation marker. MDRX, ...

Veradigm stock was last at USD 4.90 on October 2, 2026, after a USD 0.10 daily decline. Its preliminary 2025 revenue range is USD 584-589 million. MDRX, US01988P1084, Illustration mit AI erstellt.

San Francisco-based Innovaccer has appointed Paul Black, former CEO of Allscripts, to its board of directors, according to a news release shared with Becker’s. Mr. Black led Allscripts from 2012 to ...

Richard J. Poulton is currently the Chief Executive Officer & Director at Allscripts Healthcare LLC, the Director at Juvenile Diabetes Research Foundation of Arizona, Inc., and the President & Chief ...